C4 Therapeutics, Inc. (CCCC) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -29.94M | -22.14M | -31.21M | -12.06M | -33.28M | -17.93M | -24.13M | -4.97M | -18.12M | -24.01M | -30.71M | -19M | -33.13M | -29.13M | -28.02M | -22.2M | -26.6M | -25.67M | -18.36M | -18M |
| Operating CF Margin % | -486.74% | -201.03% | -277.89% | -186.55% | -459.86% | -346.38% | -157.1% | -41.43% | -596.18% | -736.25% | -277.34% | -713.1% | -881.22% | -1020.6% | -414.87% | -160.44% | -347.48% | -127.86% | -215.98% | -184.05% |
| Operating CF Growth % | 10.04% | -23.49% | -29.31% | -142.4% | -83.71% | 25.31% | 21.41% | 73.82% | 45.3% | 17.57% | -9.59% | 14.41% | -24.55% | -13.47% | -52.63% | -23.29% | -6.67% | -19.18% | -27.05% | -23.35% |
| Net Income | -25.13M | -20.49M | -32.17M | -26.02M | -26.32M | -34.57M | -24.67M | -17.72M | -28.36M | -34.75M | -27.04M | -35.92M | -34.78M | -37.19M | -31.96M | -27.41M | -31.62M | -15.66M | -24.68M | -22.58M |
| Depreciation & Amortization | 1.8M | 428K | 460K | 2.08M | 456K | 480K | 442K | 448K | 448K | 1.69M | 447K | 458K | 545K | 521K | 1.92M | 435K | 305K | 758K | 330K | 388K |
| Stock-Based Compensation | 0 | 4.01M | 4.59M | 0 | 5.51M | 8.23M | 8.83M | 6.38M | 6.21M | 6.36M | 8.2M | 6.42M | 6.25M | 6.92M | 0 | 8.15M | 8.94M | 0 | 6.09M | 5.23M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20.87M | -472K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.66M | 587K | 11.94M | 4.63M | 892K | 503K | 260K | 45K | 223K | 20.16M | 1.65M | 667K | 1.08M | 1.28M | 6.23M | 2.3M | 2.02M | 7.38M | 1.07M | 877K |
| Working Capital Changes | -8.27M | -6.68M | -16.03M | 7.25M | -13.82M | 7.42M | -9M | 5.87M | 3.36M | 3.4M | -13.5M | 9.38M | -6.22M | -660K | -4.21M | -5.67M | -6.24M | -18.15M | -1.16M | -1.92M |
| Change in Receivables | -482K | 4.14M | -4.34M | 5.83M | -4.93M | 7.24M | -9.17M | 12.43M | -1.8M | -11.3M | 528K | -500K | 945K | 15K | 222K | 63K | 3.94M | -871K | 1.37M | -2.56M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.62M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -85K | -472K | -885K | 1.53M | -645K | -176K | 590K | -715K | 182K | 169K | -837K | 1.08M | -138K | -1.08M | -1.69M | 588K | -1.15M | 760K | -601K | 627K |
| Cash from Investing | 16.15M | -80.73M | 4.09M | 38.92M | 29.13M | 13.67M | 162K | -11.71M | -53.4M | 31.95M | 57.73M | 15.15M | 53.53M | 9.28M | 19.91M | 33.23M | -4M | -59.41M | -100.63M | 32.43M |
| Capital Expenditures | -64K | -11K | -411K | -185K | 0 | 4K | 13K | -197K | 0 | -157K | -600K | -362K | -589K | -1.49M | -3.31M | -529K | -172K | -109K | 0 | -747K |
| CapEx % of Revenue | 1.04% | 0.1% | 3.66% | 2.86% | - | 0.08% | 0.08% | 1.64% | - | 4.81% | 5.42% | 13.59% | 15.67% | 52.21% | 48.93% | 3.82% | 2.25% | 0.54% | - | 7.64% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -32.1M | -58.33M | 0 | -54.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32.1M | 58.33M | 0 | 54.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 462K | 118.67M | 7.77M | 0 | -46K | 112K | 10.51M | 135K | 34.58M | 57.67M | -10.75M | -746K | -684K | 47K | 361K | 259K | 480K | 466K | 584K | 170.5M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11M | -750K | -750K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 406K | 118.67M | 7.5M | 0 | -155K | 111K | 10.2M | 135K | 33.98M | 57.67M | -16K | 0 | -38K | 0 | 211K | 0 | 0 | 752K | -469K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -200K | -14K | -24K | 0 | -155K | 0 | -85K | 0 | -109K | 0 | -16K | 0 | -94K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 56K | 1K | 271K | 0 | 109K | 1K | 310K | 0 | 603K | -1K | 263K | 4K | 104K | 47K | 150K | 259K | 480K | -286K | 1.05M | 170.5M |
| Net Change in Cash | -13.33M | 15.79M | -19.35M | 26.86M | -4.21M | -4.15M | -13.46M | -16.55M | -36.93M | 65.62M | 16.27M | -4.59M | 19.72M | -19.8M | -7.75M | 11.29M | -30.12M | -86.62M | -118.4M | 184.93M |
| Free Cash Flow | -30.01M | -22.16M | -31.62M | -12.24M | -33.28M | -17.93M | -24.12M | -5.17M | -18.12M | -24.17M | -31.31M | -19.36M | -33.71M | -30.62M | -31.32M | -22.72M | -26.77M | -25.78M | -18.36M | -18.75M |
| FCF Margin % | -487.78% | -201.13% | -281.55% | -189.42% | -459.86% | -346.3% | -157.01% | -43.07% | -596.18% | -741.06% | -282.76% | -726.69% | -896.89% | -1072.81% | -463.8% | -164.26% | -349.73% | -128.4% | -215.98% | -191.69% |
| FCF Growth % | 9.85% | -23.58% | -31.09% | -136.74% | -83.71% | 25.81% | 22.96% | 73.29% | 46.26% | 21.07% | 0.06% | 14.81% | -25.95% | -18.77% | -70.63% | -21.2% | -5.57% | -18.09% | -24.6% | -29.44% |
| FCF per Share | -0.24 | -0.19 | -0.44 | -0.17 | -0.47 | -0.25 | -0.35 | -0.08 | -0.26 | -0.47 | -0.64 | -0.39 | -0.69 | -0.63 | -0.64 | -0.47 | -0.55 | -0.53 | -0.38 | -0.43 |
| FCF Conversion (FCF/Net Income) | 1.19x | 1.08x | 0.97x | 0.46x | 1.26x | 0.52x | 0.98x | 0.28x | 0.64x | 0.69x | 1.14x | 0.53x | 0.95x | 0.78x | 0.88x | 0.81x | 0.84x | 1.64x | 0.74x | 0.80x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -13K | 0 | 422K | 0 | 421K | 0 | 355K | 473K | 0 | 363K | 349K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |